The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology

被引:0
|
作者
Henrik von Wenckstern
Karsten Zimmermann
Burkhard Kleuser
机构
[1] Freie Universität Berlin,Institute of Pharmacy, Pharmacology and Toxicology
关键词
sphingolipids; sphingosine 1-phosphate; FTY720; immunosuppression; T cell; dendritic cell;
D O I
暂无
中图分类号
学科分类号
摘要
Sphingosine 1-phosphate (S1P) has been shown to be a bioactive lipid mediator intimately involved in mediating a variety of immunological processes. In particular, S1P regulates lymphocyte cell trafficking between the lymphatic system and the blood. The lysophospholipid signals mainly through five related G protein-coupled receptor subtypes, termed S1P1 to S1P5. S1P1 seems to play an essential role in cell trafficking, as this receptor subtype promotes the egress of T and B cells from secondary lymphatic organs. This S1P1-mediated migratory response is a consequence of different S1P levels in the serum and lymphatic organs. In addition to its direct effects on lymphocyte motility, S1P strengthens cell barrier integrity in sinus-lining endothelial cells, thereby reducing lymphocyte egress out of lymph nodes. Furthermore, S1P modulates cytokine profiles in T and dendritic cells, resulting in an elevated differentiation of T helper-2 cells during the T cell activation process. It is of interest that the mode of molecular action of the novel immunomodulator FTY720 interferes with the signaling of S1P. After phosphorylation, FTY720 shares structural similarity with S1P, but in contrast to the natural ligand, phosphorylated FTY720 induces a prolonged internalization of S1P1, resulting in an impaired S1P-mediated migration of lymphocytes.
引用
收藏
页码:239 / 251
页数:12
相关论文
共 50 条
  • [41] Binding of sphingosine 1-phosphate to cell surface receptors
    Van Brocklyn, JR
    Spiegel, S
    SPHINGOLIPID METABOLISM AND CELL SIGNALING, PT B, 2000, 312 : 401 - 406
  • [42] Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells
    Yatomi, Y
    Ohmori, T
    Ge, RL
    Kazama, F
    Okamoto, H
    Sano, T
    Satoh, K
    Kume, S
    Tigyi, G
    Igarashi, Y
    Ozaki, Y
    BLOOD, 2000, 96 (10) : 3431 - 3438
  • [43] Author Correction: Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel
    Bram Verstockt
    Stefania Vetrano
    Azucena Salas
    Shadi Nayeri
    Marjolijn Duijvestein
    Niels Vande Casteele
    Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 410 - 410
  • [44] Sphingosine 1-phosphate receptors
    Hla, T
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 64 (1-4): : 135 - 142
  • [45] Sphingosine 1-Phosphate and Atherosclerosis
    Kurano, Makoto
    Yatomi, Yutaka
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (01) : 16 - 26
  • [46] Sphingosine 1-phosphate signalling
    Mendelson, Karen
    Evans, Todd
    Hla, Timothy
    DEVELOPMENT, 2014, 141 (01): : 5 - 9
  • [47] Sphingosine 1-phosphate and inflammation
    Obinata, Hideru
    Hla, Timothy
    INTERNATIONAL IMMUNOLOGY, 2019, 31 (09) : 617 - 625
  • [48] Sphingosine 1-phosphate and cancer
    Nigel J. Pyne
    Susan Pyne
    Nature Reviews Cancer, 2010, 10 : 489 - 503
  • [49] Sphingosine 1-phosphate and cancer
    Pyne, Nigel J.
    Pyne, Susan
    NATURE REVIEWS CANCER, 2010, 10 (07) : 489 - 503
  • [50] Sphingosine Kinase and Sphingosine 1-Phosphate in Cardioprotection
    Karliner, Joel S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 53 (03) : 189 - 197